Article
CD95 rs1800682 polymorphism and cervical cancer risk: evidence from a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Mar 2014
Zhang Yan, Tong Shengchun, Guan Lihua, Na Fei, Zhao Wei, Wei Li
Abstract excerpt
CD95 is the first death receptor identified and characterized in recent years, and it plays important roles in the molecular network regulating cell death and survival. CD95 rs1800682 polymorphism is a common genetic polymorphism identified in the CD95 gene. Many publications evaluated the association between CD95 rs1800682 polymorphism and cervical cancer risk, but the association remained inconclusive. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
